ema prac naion semaglutide Meeting highlights from the Pharmacovigilance Risk Assessment Committee ( PRAC) 13-16 January 2025 Blinded by the drug? A

Semaglutide works for weight loss by slowing down digestion , controlling the release of insulin and glucagon after you eat, and sending signals to your brain that enhance feelings of fullness and reduce your cravings for certain foods

As your body adapts and your goals evolve, your care plan is adjusted to keep your progress safe, measurable, and built for the long run

Ozempic, on the other hand, has a well-established track record and a strong safety profile

What is the regulatory status of the KLOW Blend

Impact on Donor Safety These physiological changes do not automatically affect eligibility, but they can influence how well someone tolerates the donation process

QC is not just testing - it's risk detection before the patient ever sees the drug